Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
about
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitorsNovel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration.Nucleic acid binding agents exert local toxic effects on neurites via a non-nuclear mechanism.Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapyZalcitabine population pharmacokinetics: application of radioimmunoassay.Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosidesDifferential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats.Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complexPaclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cellsExonuclease removal of dideoxycytidine (zalcitabine) by the human mitochondrial DNA polymerase.HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.Mitochondrial biogenesis in the axons of vertebrate peripheral neuronsSubclinical peripheral nerve involvement in AIDS: an electrophysiological and pathological study.The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Initial clinical experience with dideoxynucleosides as single agents and in combination therapy.Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC).Recent advances in the neurology of HIV infectionEffect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture.Zalcitabine.Efficient incorporation of anti-HIV deoxynucleotides by recombinant yeast mitochondrial DNA polymerase.Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: effects of its triphosphate on mammalian DNA polymerases.Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
P2860
Q24536268-7C9A7C01-3E6E-42F4-904E-E77048FFE5E3Q28344795-A301E9D0-FFD9-4F05-BA88-771058F0C9F8Q30885827-4E949CC5-008E-4900-9CA2-2E2423838788Q33232600-541F6AD7-8555-4363-A276-ADB7BAE4A183Q33607809-705C5D33-B76C-40FB-9D1F-7A98611F8C05Q33690050-A7F0137C-B968-42E3-9CDE-EE5AC50688B9Q33757004-744C0BA7-09FF-4C77-AB0A-15B4E93FD00DQ33978880-C49B3778-5117-48EA-B996-F17250A55F15Q34282667-794FAC61-2975-4A7D-A794-7F12D3BEC1A8Q34283144-641624B3-05A2-420B-9CC3-E092910319AFQ35318098-A61EA839-C356-490A-9ADC-1F333A01AF1BQ35561043-3C1C90C4-391C-4DEB-A379-CB5217F0CF10Q35652741-CF9C9FB5-A029-40D3-892C-B34DF3613D14Q36422647-C57DC8A4-4EC1-461A-B46A-B0220B97C7ABQ36476904-213E65E2-4206-4EC7-A141-0609499C5700Q36883274-EE1F270F-B659-46D5-949F-EAD5EB972626Q36946328-CAEEF677-7311-4389-BCE8-FE280A5D0C45Q37149019-63DA6CA5-C02B-45DB-A5CD-0F1CCDC357EDQ37783043-BBFA2694-58EF-464C-9880-D44F463E1605Q37798546-8D8ECEAA-FCF5-44BE-A645-40A95D97A0A4Q38405371-A1941F64-D9C5-4866-8EC6-DF2011C4940AQ38633801-FFDCEF70-4443-45C1-8581-17CA7F911D04Q40286276-88DF921D-1B74-4A1F-8C57-C5F0DEA8B019Q40709556-17181B8D-1334-4AF2-83C7-00C7EF2739FEQ40975672-2150D110-F409-4813-9F91-DB9ECF292843Q43592354-E4E0A1F2-8DC1-484B-91EF-2F6BA6609F60Q43619714-59584ED3-63A1-4E59-9403-250E89D4B4D8Q43797776-0C26B751-B55B-410E-A7D8-B6609D20319C
P2860
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@ast
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@en
type
label
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@ast
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@en
prefLabel
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@ast
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@en
P2093
P356
P1433
P1476
Reversible axonal neuropathy f ...... h 2',3'-dideoxycytidine (ddC).
@en
P2093
R M Dubinsky
R Yarchoan
P304
P356
10.1002/MUS.880121012
P577
1989-10-01T00:00:00Z